Stephen P. Hunger

Children's Hospital of Philadelphia

Papers

1

Total Citations

2

H-Index

1

About

Dr. Stephen P. Hunger is a world-renowned pediatric oncologist whose research has fundamentally reshaped the treatment of childhood acute lymphoblastic leukemia (ALL). His work focuses on identifying high-risk genetic subtypes and translating these discoveries into targeted therapies. Dr. Hunger is best known for leading landmark clinical trials through the Children’s Oncology Group, which established new standards of care and dramatically improved survival rates. He has been instrumental in characterizing the biology of rare, aggressive ALL subtypes, such as those with *TCF3-HLF* rearrangements, demonstrating significant *in vivo* sensitivity to Aurora kinase inhibition. With over 500 publications and more than 40,000 citations, his impact on the field is immense. Dr. Hunger’s contributions have been recognized with numerous awards, including the St. Baldrick’s Foundation Robert J. Arceci Innovation Award, and he serves as a leading voice in global efforts to cure all children with leukemia.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Significant In Vivo Sensitivity to Aurora Kinase Inhibition in TCF3-Hlf rearranged Acute Lymphoblastic Leukemia
2 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Children's Hospital of Philadelphia

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago